Subscribe
Healthcare

Democrats shift focus to lowering insulin costs

By Cassidy Morrison
Published
Add Washington Examiner on Google
Democrats shift focus to lowering insulin costs

Democrats in Congress have shifted their attention to lowering the cost of insulin, a narrow drug pricing reform policy goal after their agenda stalled earlier this year with the failure of the Build Back Better plan.

Senate Majority Leader Chuck Schumer, a New York Democrat, said earlier this week that he would work to advance cost-cutting measures this spring, which would provide the party a much-needed win ahead of the November midterm elections.

Print subscriber? Click here to login/register your account
Digital subscriber? Click here to login/register your account.

Full midterm coverage.Deeper analysis.

Get unlimited access to Washington Examiner's reporting, expert analysis, and coverage of the midterm elections.

Get Unlimited Access

Cancel anytime.

Tag:

Democrats Jeanne Shaheen Medicine Midterm Elections Pharmaceutical Industry Raphael Warnock Ron Wyden Senate Democrats Washington D.C.